Observations of elevated intraocular ANG2 concentrations in patients with diabetic retinopathy and retinal vein occlusion underscore the potential clinical relevance of ocular ANG2 inhibition [19]. The gene discussed is ANGPT2; the disease is retinal vein occlusion.